Liposomal Nanoparticle Ear Drops for Non-Invasive Middle Ear Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for diagnosing and treating ear infections, such as otitis media, are prone to errors and have limitations, including non-specific biodistribution of antibiotics and the need for invasive procedures like surgical tube insertion and general anesthesia.
Innovation Solution
A method involving liposomal nanoparticles that can be delivered as ear drops to penetrate the tympanic membrane and round window without damage, allowing for targeted delivery of imaging, diagnostic, or therapeutic agents to the middle or inner ear for accurate diagnosis and treatment.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional antibiotic administration (systemic intravenous injection or oral administration) is used, then treatment of ear infections can be achieved, but non-specific biodistribution and high-dosage administration are required
Solution Approach 1:
The patent segments the delivery system into nanoparticle carriers that can be locally administered to the ear, dividing the treatment from systemic circulation and enabling targeted delivery to the middle ear, thereby reducing the overall dosage required while maintaining treatment efficacy
Solution Approach 2:
The patent introduces nanoparticle carriers as intermediary vehicles that transport antibiotics directly to the infection site in the middle ear, acting as a mediator between the administered drug and the target tissue, which improves biodistribution specificity and reduces the dosage needed
2Ease of operation
If surgical insertion of a tube into the tympanic membrane is performed, then thick fluid can be removed by suction, but general anesthesia and multiple post-operative check-ups are required
Solution Approach 1:
The patent replaces the mechanical surgical intervention (tube insertion and suction) with a chemical/biological approach using nanoparticle-mediated antibiotic delivery that can treat the infection without physical surgery, thereby eliminating the need for general anesthesia and post-operative monitoring
Solution Approach 2:
The patent uses nanoparticle carriers as intermediaries to deliver therapeutic agents directly to the infected middle ear space, substituting the need for surgical tubes by providing an alternative pathway for drug delivery that achieves fluid clearance through anti-inflammatory and antimicrobial effects
3Difficulty of detecting and measuring
If pneumatic otoscopy is used for diagnosis, then fluid presence in the middle ear can be detected, but erroneous interpretation by the practitioner occurs
Solution Approach 1:
The patent employs fluorescent probes that undergo color/fluorescence changes when they bind to specific bacterial components or inflammatory markers in the middle ear fluid, providing an objective visual signal that reduces practitioner interpretation errors and improves diagnostic precision
Solution Approach 2:
The patent introduces fluorescent probes as intermediary agents that mediate between the diagnostic process and the practitioner, converting invisible bacterial or inflammatory markers into detectable fluorescent signals, thereby eliminating subjective interpretation errors
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides a non-invasive, painless, and cost-effective method for diagnosing and treating ear infections, reducing the risk of complications and improving treatment efficacy while minimizing doctor visits and overall healthcare costs.
Implementation Method 1
penetrating without damaging the tympanic membrane or round window with the nanoparticle
Implementation Method 2
The imaging agent can include an inflammation targeted probe that will fluoresce further including a step of detecting a presence of a fluid and/or an indication of whether the fluid is infected
Data Source
AI summary
This application relates to various methods, agents, and systems for delivery of imaging and therapeutic agents to the middle and inner ear. On one aspect, there is a formulation provided in an ear drop form factor based on liposomal nanoparticles that penetrate the eardrum without an incision and can deliver therapeutic agents and/or contrast agents to the middle ear or therapeutic medications to the inner ear.